| Variable |
Total sample n=55 |
| Baseline |
4 months Follow-up |
| Mean (SD) or median |
Range |
Mean (SD) |
Range |
| Age (years) |
57.7 (8.27) |
45-81 |
57.9 (8.25) |
46-81 |
| Education (years) |
14.3 (2.76) |
7-20 |
- |
- |
| % Male |
96% |
- |
- |
- |
| % Caucasian |
95% |
- |
- |
- |
| Nadir CD4 count (cp/mL) (IQR) |
199 |
80-300 |
|
|
| Current CD4 (cp/mL) (IQR) |
560 |
400-672 |
|
|
| Plasma HIV RNA (cp/mL) |
98.2% Undetectable (54/55) |
|
|
|
| CSF HIV RNA (n=23) (cp/mL) |
100% Undetectable (24/24) |
|
|
|
| % AIDS (1993 CDC definition) |
69.1% |
|
|
|
| % AIDS defining illness |
36.4% |
|
|
|
| Median HIV duration (years) (IQR) |
19.6 |
14.1-25.6 |
|
|
| HAND AAN 2007 diagnosis |
49.1% Hand (27/55) |
29.1%ANI (16/55) |
| |
|
12.7% MND (7/55) |
| |
|
7.3% HAD (4/55) |
Note: Undetectable is <50copies/mL, ANI: asymptomatic neurocognitive impairment, MND: Mild Neurocognitive Disorder, HAD: HIV-Associated Dementia |
